chartexchange

REPL
Replimune Group, Inc.
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
19.80USD+0.559%(+0.11)2,130,117
Pre-marketNov 18, 2026 9:20:30 AM EST
19.54USD-0.762%(-0.15)
After-hoursNov 18, 2026 4:11:30 PM EST
19.83USD+0.152%(+0.03)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Woburn, MA, USA
Previous Close
$19.69
Beta
0.83
52-Week High
$23.54 2026-11-11
52-Week Low
$1.50 2026-04-13
SMA 50
$15.10
SMA 200
$10.20
Avg. Vol 10D
2.77M
Avg. Vol 30D
2.89M
Avg. Vol 90D
3.84M
Relative Vol
0.74
89.16M
24,609,876
0.2800%
4,700,000
561
REPL Profile

replimune group, inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. it uses its proprietary immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. the company's lead product candidate is rp1, a selectively replicating version of herpes simplex virus 1, which is in phase i/ii clinical trials for a range of solid tumors; and that is in phase ii clinical trials for patients with cutaneous squamous cell carcinoma. it is also developing rp2, which is in phase i clinical trials for an anti-ctla-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by ctla-4; and rp3 to express immune-activating proteins that stimulate t cells. replimune group, inc. was founded in 2015 and is headquartered in woburn, massachusetts.

REPL Performance
PeriodPriceDateChangeBeta
1W21.982026-11-12-9.92%1.964
1M11.052026-10-19+79.19%1.224
3M14.812026-08-19+33.69%1.091
6M4.702026-05-19+321.28%2.195
1Y8.992025-11-19+120.25%0.834
2Y10.952024-11-19+80.82%—
5Y34.252021-11-19-42.19%0.088
REPL Stock Summary

Replimune Group, Inc. (NASDAQ:REPL) stock price today is $19.80, and today's volume is 2,130,117. REPL is up 0.559% today. The 30 day average volume is 2.89M. REPL market cap is $1.88B with 94.80M shares outstanding.